Skip to main content
PEN logo
PEN
(NYSE)
Penumbra, Inc.
$317.63-- (--)
Loading... - Market loading

Penumbra (PEN) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Penumbra, Inc.
PENNew York Stock ExchangeHealthcareMedical Devices

About Penumbra

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

Company Information

CEOAdam Elsesser
Founded2004
IPO DateSeptember 18, 2015
Employees4,700
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNew York Stock Exchange (NYSE)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone510 748 3200
Address
One Penumbra Place Alameda, California 94502 United States

Corporate Identifiers

CIK0001321732
CUSIP70975L107
ISINUS70975L1070
SIC3841

Leadership Team & Key Executives

Adam Elsesser J.D.
Co-Founder, Chairman and Chief Executive Officer
Shruthi Narayan
President
Dr. Arani Bose M.D.
Co-Founder and Director
Maggie S. Yuen
Chief Financial Officer
Lambert Shiu
Chief Accounting Officer
Johanna Roberts J.D.
Executive Vice President, General Counsel and Secretary
Ben Sorci
Executive Vice President of Operations
Pankaj Tiwari
Executive Vice President and Chief Information Officer
Jee Hamlyn-Harris
Investor Relations Officer
Ben Tompkins
Executive Vice President of Development and Compliance